Literature DB >> 12956852

Dysfibrinogenemia during pregnancy treated successfully with fibrinogen.

Yoshihiko Yamanaka1, Kyousuke Takeuchi, Makoto Sugimoto, Asomi Sato, Satoshi Nakago, Takeshi Maruo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12956852     DOI： 10.1034/j.1600-0412.2003.00211.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  4 in total

1.  Management of dysfibrinogenemia in pregnancy: A case report.

Authors:  Jie Yan; Donghong Deng; Peng Cheng; Lin Liao; Meiling Luo; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2017-09-26       Impact factor: 2.352

2.  A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.

Authors:  Jie Yan; Meiling Luo; Peng Cheng; Lin Liao; Xuelian Deng; Donghong Deng; Faquan Lin
Journal:  Int J Hematol       Date:  2016-12-08       Impact factor: 2.490

3.  Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis.

Authors:  Apar Kishor Ganti; Julie M Vose; William D Haire
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

Review 4.  Update on inherited disorders of haemostasis and pregnancy.

Authors:  Orly Lavee; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2016-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.